Vanderbilt Heart and Vascular Institute Archives
Age no barrier for patient’s transplant surgery success
Aug. 18, 2016—The old adage that age is just a number actually became a lifesaver for 71-year-old Rex Parton.
Heart transplant program among busiest in U.S.
Aug. 4, 2016—Vanderbilt University Medical Center’s heart transplant program is ranked No. 2 nationwide in volume for its combined adult and pediatric procedures, according to the most recent data released by Organ Procurement and Transplant Network (OPTN) in July.
Heart Institute celebrates LVAD program milestone
Apr. 14, 2016—On April 7, a 48-year-old man from Bethpage, Tennessee, became the 300th person to receive a left ventricular assist device (LVAD) at Vanderbilt Heart and Vascular Institute (VHVI).
Study leads to new heart transplant decision support tool
Feb. 18, 2016—Because donor organs are scarce, understanding the mortality risk associated with heart transplantation is an important consideration when evaluating patients for transplant.
Clair named Heart Institute Executive Medical Director
Nov. 5, 2015—After serving in an interim capacity, Walter Clair, M.D., MPH, associate professor of Medicine and medical director of Cardiac Electrophysiology, has been named executive medical director of the Vanderbilt Heart and Vascular Institute (VHVI).
Shah named to direct VHVI’s heart transplant program
Oct. 15, 2015—Ashish Shah, M.D., has joined Vanderbilt Heart and Vascular Institute (VHVI) as director of Heart Transplant and Mechanical Circulatory Support.
New device monitors pulmonary artery pressures
Aug. 20, 2015—For patients with heart failure, changes in pulmonary artery (PA) pressures are an early indication that their condition is worsening, even before they notice symptoms such as shortness of breath or weight gain.
VUMC recognized for high standard of cardiac care
Aug. 6, 2015—The American College of Cardiology has recognized Vanderbilt University Medical Center (VUMC) for its commitment to and success in implementing a higher standard of care for heart attack patients.
Vanderbilt Heart offers alternative to blood thinners for atrial fibrillation
Jun. 17, 2015—Vanderbilt Heart and Vascular Institute now offers patients with atrial fibrillation (AF) an alternative treatment to reduce their risk of stroke, potentially avoiding the long-term use of blood thinners such as warfarin.
Former heart patient inspired to create Discovery Science Fund
Jun. 11, 2015—Two vastly different causes of heart failure, both of which can devastate a patient’s life, are being studied at Vanderbilt University Medical Center thanks, in part, to the generosity of a grateful patient whose own damaged heart was repaired at Vanderbilt more than five years ago.
Vitamin D found to have no impact on blood pressure
Feb. 19, 2015—Despite prior epidemiologic and experimental data to the contrary, new research shows that vitamin D supplementation does not reduce blood pressure in individuals with prehypertension or stage I hypertension and vitamin D deficiency.
Study to explore myeloma treatment’s impact on heart
Feb. 5, 2015—Vanderbilt is embarking on an observational study to define and understand how a promising treatment for multiple myeloma affects the heart.
